Company intelligence / Profile preview

Zhejiang Peptites Biotech

Shengzhou, Zhejiang, Chinapeptide-china.com ↗

Ownership: Private
Employees: ~700
Development stage: Commercial

Overview

Zhejiang Peptites Biotech is a leading Chinese manufacturer of cGMP-grade peptide active pharmaceutical ingredients with over 40 commercialized APIs. The company supplies both generic and custom peptides for pharmaceutical and cosmetic use globally. It has significant manufacturing capacity (>500 kg/year) and advanced synthesis/purification technology. No clinical trial results are reported as the company focuses on manufacturing rather than proprietary drug development.

Therapeutic areas: OncologyEndocrinologyWomen's Health
Modalities: PeptidesRecombinant proteinSmall molecule
Industry: Contract Manufacturing Organization

Drug pipeline

1 asset

semaglutide

Commercial

Indications: Type 2 diabetes, Obesity

Beyond the preview

Go deeper on Zhejiang Peptites Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Peptites Biotech.

Explore the full profile